Names and pronunciation
(koe-bi-me′ti-nib) C Cotellic
PDF page 311
Drug reference
(koe-bi-me′ti-nib) C Cotellic
PDF page 311
Func. class.: Antineoplastic
PDF page 311
USES: Orphan drug. For the treatment of unresectable or metastatic melanoma in patients with a BRAF V600E or V600K muta- tion, in combination with vemurafenib
PDF page 311
CONTRAINDICATIONS: Hyper- sensitivity
PDF page 311
DOSAGE AND ROUTES • Adult: PO 60 mg (three 20-mg tablets) daily × 21 days, in combination with vemu- rafenib 960 mg bid × 28 days; repeat cycle q28days until disease progression or unacceptable toxicity
PDF page 311
Available forms: Tablets 20 mg HIGH ALERT
PDF page 311
• Adult: PO 60 mg (three 20-mg tablets) daily × 21 days, in combination with vemu- rafenib 960 mg bid × 28 days; repeat cycle q28days until disease progression or unacceptable toxicity
PDF page 311